175 related articles for article (PubMed ID: 37762037)
21. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.
Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304
[TBL] [Abstract][Full Text] [Related]
22. A positive feedback loop between LINC01605 and NF-κB pathway promotes tumor growth in nasopharyngeal carcinoma.
Zhao W; Xin L; Tang L; Li Y; Li X; Liu R
RNA Biol; 2022; 19(1):482-495. PubMed ID: 35373703
[TBL] [Abstract][Full Text] [Related]
23. Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.
Mullany LK; Wong KK; Marciano DC; Katsonis P; King-Crane ER; Ren YA; Lichtarge O; Richards JS
Neoplasia; 2015 Oct; 17(10):789-803. PubMed ID: 26585234
[TBL] [Abstract][Full Text] [Related]
24. A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.
Subramanian M; Francis P; Bilke S; Li XL; Hara T; Lu X; Jones MF; Walker RL; Zhu Y; Pineda M; Lee C; Varanasi L; Yang Y; Martinez LA; Luo J; Ambs S; Sharma S; Wakefield LM; Meltzer PS; Lal A
Oncogene; 2015 Feb; 34(9):1094-104. PubMed ID: 24662829
[TBL] [Abstract][Full Text] [Related]
25. Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
Dhaka B; Sabarinathan R
BMC Cancer; 2021 Jun; 21(1):669. PubMed ID: 34090364
[TBL] [Abstract][Full Text] [Related]
26. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.
Gong Z; Zhang S; Zeng Z; Wu H; Yang Q; Xiong F; Shi L; Yang J; Zhang W; Zhou Y; Zeng Y; Li X; Xiang B; Peng S; Zhou M; Li X; Tan M; Li Y; Xiong W; Li G
PLoS One; 2014; 9(11):e110674. PubMed ID: 25422887
[TBL] [Abstract][Full Text] [Related]
27. P53 long noncoding RNA regulatory network in cancer development.
Aravindhan S; Younus LA; Hadi Lafta M; Markov A; Ivanovna Enina Y; Yushchenkо NA; Thangavelu L; Mostafavi SM; Pokrovskii MV; Ahmadi M
Cell Biol Int; 2021 Aug; 45(8):1583-1598. PubMed ID: 33760334
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Lu P; Vander Mause ER; Redd Bowman KE; Brown SM; Ahne L; Lim CS
J Ovarian Res; 2019 May; 12(1):45. PubMed ID: 31092272
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.
Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S
Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246
[TBL] [Abstract][Full Text] [Related]
30. Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events.
Ashouri A; Sayin VI; Van den Eynden J; Singh SX; Papagiannakopoulos T; Larsson E
Nat Commun; 2016 Oct; 7():13197. PubMed ID: 28959951
[TBL] [Abstract][Full Text] [Related]
31. Deciphering the Mounting Complexity of the p53 Regulatory Network in Correlation to Long Non-Coding RNAs (lncRNAs) in Ovarian Cancer.
Pal S; Garg M; Pandey AK
Cells; 2020 Feb; 9(3):. PubMed ID: 32106407
[TBL] [Abstract][Full Text] [Related]
32. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract][Full Text] [Related]
33. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
34. Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.
Sonego M; Schiappacassi M; Lovisa S; Dall'Acqua A; Bagnoli M; Lovat F; Libra M; D'Andrea S; Canzonieri V; Militello L; Napoli M; Giorda G; Pivetta B; Mezzanzanica D; Barbareschi M; Valeri B; Canevari S; Colombatti A; Belletti B; Del Sal G; Baldassarre G
EMBO Mol Med; 2013 May; 5(5):707-22. PubMed ID: 23610071
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
[TBL] [Abstract][Full Text] [Related]
36. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations.
Li Y; Guessous F; Kwon S; Kumar M; Ibidapo O; Fuller L; Johnson E; Lal B; Hussaini I; Bao Y; Laterra J; Schiff D; Abounader R
Cancer Res; 2008 Mar; 68(6):1723-31. PubMed ID: 18339852
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-324-5p-CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness.
Ghatak D; Datta A; Roychowdhury T; Chattopadhyay S; Roychoudhury S
Mol Cancer Res; 2021 Oct; 19(10):1635-1650. PubMed ID: 34257080
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
39. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract][Full Text] [Related]
40. An N
Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
